Top pharma company signs up to Astech's technical support service

Published: 14-Oct-2008
Manufacturing Research & Development

Astech based in Runcorn, UK says that one of the world's top five pharmaceutical companies has just signed up for its "REACTS" service that supports manufacturing QC and product development testing automation at a key European site.


Astech based in Runcorn, UK says that one of the world's top five pharmaceutical companies has just signed up for its "REACTS" service that supports manufacturing QC and product development testing automation at a key European site.

REACTS - Rapid, Effective And Complete Technical Support - is an extension of the customer service offered by Astech, combining its long-standing automation experience and extensive engineering expertise.

The REACTS team provides automation installation and maintenance services, as well as technical support for any automation system in the drug discovery and pharmaceutical manufacturing sectors throughout Europe, North America and Asia.

  • Companies:
  • Astech Projects
See more

You may also like

Manufacturing

Xelox 1 workstation becomes more versatile

Read more
Enhancements include multiple DUSA does collection chambers

Trending Articles

  1. Innovation in generics: increased efficiency through peptide API synthesis expertise Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
  2. COVID-19 still a significant risk for the immunocompromised, study finds AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
  3. US court lifts modified consent decree on Xellia’s Cleveland facility The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
  4. Lonza's AI-enabled small molecule development tool launches The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
  5. N4 Pharma and SRI to target and treat previously unreachable human cells The companies will collaborate to perform research to conjugate SRI’s MGS system to Nuvec to increase intracellular delivery to specific target cells.

Upcoming event

ASGCT Annual Meeting 2024

7-11 May, 2024 | Meeting | Portland, OR See all

You may also like

Manufacturing

Xelox 1 workstation becomes more versatile

Enhancements include multiple DUSA does collection chambers
Manufacturing

Astech Projects launches Xelair Series 5 automated inhaler tester

<p>Astech Projects, a Cheshire, UK-based manufacturer of automation solutions, has introduced the Xelair Series 5 system for automated inhaler testing. </p>
Manufacturing

Astech system analyses drug content

<p>Advanced automated system solutions supplier Astech Projects has launched a new tablet processing system for drug content analysis.</p>
Manufacturing

Astech launches fast system for Andersen Cascade Impactor inhaler test

<p>Runcorn-based drug delivery testing system provider Astech Projects has developed an automated solution for the Andersen Cascade Impactor inhaler test.</p>
Manufacturing

CPI collaborates with industry leaders to expedite drug manufacturing via digitisation

Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Manufacturing

Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide

CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
Research & Development

OGT launches new SureSeq myeloid fusion panel drive myeloid cancer research

The assay enables users to integrate research techniques with a single, streamlined NGS process, expediting the process
Subscribe now